Vous n'êtes pas identifié (connexion)

Centre de recherche

BOTTIN

Gaston De Serres

Formation
à venir

Aucune offre active

Autres opportunités de carrière
Axe principal
Maladies infectieuses et immunitaires
Adresse(s)
2400, avenue d'Estimauville, 3e étage

Québec (Québec)
CANADA G1E 7G9

Téléphone(s)
+1 418-666-7000, poste 274
Télécopieur(s)
+1 418-666-2776
Courriel(s)
Gaston.DeSerres@inspq.qc.ca

Publications récentes (voir toutes les publications de ce chercheur)

Boikos C, Papenburg J, Martineau C, Joseph L, Scheifele D, Chilvers M, Lands LC, De Serres G, Quach C. Viral interference and the live-attenuated intranasal influenza vaccine: Results from a pediatric cohort with cystic fibrosis. Human vaccines & immunotherapeutics,  2017. Epub
De Serres G, Skowronski DM, Ward BJ, Gardam M, Lemieux C, Yassi A, Patrick DM, Krajden M, Loeb M, Collignon P, Carrat F. Influenza Vaccination of Healthcare Workers: Critical Analysis of the Evidence for Patient Benefit Underpinning Policies of Enforcement. PLoS ONE,  2017. 12: e0163586
Skowronski DM, Chambers C, Sabaiduc S, Dickinson JA, Winter AL, De Serres G, Drews SJ, Jassem A, Gubbay JB, Charest H, Balshaw R, Bastien N, Li Y, Krajden M. Interim estimates of 2016/17 vaccine effectiveness against influenza A(H3N2), Canada, January 2017. Euro surveillance : bulletin europeen sur les maladies transmissibles = European communicable disease bulletin,  2017. 22:
De Wals P, Deceuninck G, Lefebvre B, Tsang R, Law D, De Serres G, Gilca V, Gilca R, Boulianne N. Impact of an immunization campaign to control an increased incidence of Serogroup B meningococcal disease in one region of Quebec, Canada. Clinical infectious diseases : an official publication of the Infectious Diseases Society of America,  2017. Epub
Skowronski DM, Chambers C, De Serres G, Sabaiduc S, Winter AL, Dickinson JA, Gubbay JB, Fonseca K, Drews SJ, Charest H, Martineau C, Krajden M, Petric M, Bastien N, Li Y, Smith DJ. Serial vaccination and the antigenic distance hypothesis: effects on influenza vaccine effectiveness during A(H3N2) epidemics in Canada, 2010-11 to 2014-15. The Journal of infectious diseases,  2017. Epub
Papenburg J, Charland KM, DE Serres G, Buckeridge DL. The accuracy and timeliness of neuraminidase inhibitor dispensing data for predicting laboratory-confirmed influenza. Epidemiology and infection,  2016. 144: 1592-600
Chambers C, Skowronski DM, Sabaiduc S, Winter AL, Dickinson JA, De Serres G, Gubbay JB, Drews SJ, Martineau C, Eshaghi A, Krajden M, Bastien N, Li Y. Interim estimates of 2015/16 vaccine effectiveness against influenza A(H1N1)pdm09, Canada, February 2016. Euro surveillance : bulletin europeen sur les maladies transmissibles = European communicable disease bulletin,  2016. 21:
Skowronski DM, Chambers C, Gilca R, De Serres G. Repeat Influenza Vaccination and High-Dose Efficacy. Clinical infectious diseases : an official publication of the Infectious Diseases Society of America,  2016. Epub
Skowronski DM, Chambers C, Sabaiduc S, De Serres G, Winter AL, Dickinson JA, Krajden M, Gubbay JB, Drews SJ, Martineau C, Eshaghi A, Kwindt TL, Bastien N, Li Y. A perfect storm: Impact of genomic variation and serial vaccination on low influenza vaccine effectiveness during the 2014-15 season. Clinical infectious diseases : an official publication of the Infectious Diseases Society of America,  2016. Epub
Shuel M, Lefebvre B, Whyte K, Hayden K, De Serres G, Brousseau N, Tsang RS. Antigenic and genetic characterization of Bordetella pertussis recovered from Quebec, Canada, 2002-2014: detection of a genetic shift. Canadian journal of microbiology,  2016. 62: 437-41
© 2017 Tous droits réservés Centre de recherche du CHU de Québec